Insider Trading April 13, 2026 04:49 PM

Braze General Counsel Disposes $710K in Shares Ahead of Planned Retirement

Susan Wiseman sold 35,000 Class A shares at a weighted average of $20.29 amid recent stock weakness and mixed analyst adjustments

By Caleb Monroe BRZE
Braze General Counsel Disposes $710K in Shares Ahead of Planned Retirement
BRZE

Braze, Inc. general counsel Susan Wiseman sold 35,000 shares of Class A common stock on April 9, 2026, for $710,150, according to an SEC Form 4 filing. The transaction occurred as the share price has fallen sharply year-to-date; analysts have issued divergent price target changes even as firms highlighted solid bookings and revenue growth.

Key Points

  • Susan Wiseman sold 35,000 Class A shares on April 9, 2026, at a weighted average price of $20.29, totaling $710,150.
  • Braze's stock has declined 18% over the prior week and 45% year-to-date, while InvestingPro’s Fair Value assessment indicates the company appears undervalued.
  • Analyst reactions vary: Raymond James raised its price target to $27 with an Outperform; Piper Sandler cut its target to $27 but kept Overweight; UBS lowered its target to $28 but maintained a Buy rating.

Susan Wiseman, general counsel and secretary of Braze, Inc. (NASDAQ: BRZE), reported the sale of 35,000 shares of Class A common stock on April 9, 2026, in a Form 4 filed with the Securities and Exchange Commission. The disposition carried a weighted average sale price of $20.29, producing total proceeds of $710,150.

The reported sales were executed at prices between $20.05 and $20.64 per share. After the transaction, Wiseman is listed as directly owning 209,424 shares of Braze; 103,517 of those shares are represented by restricted stock units and performance-based restricted stock units, according to the filing.

The timing of the sale comes against a backdrop of notable share-price weakness. The stock has declined 18% over the prior week and 45% year-to-date. Separately, InvestingPro analysis is cited as indicating that Braze appears undervalued at current market levels based on its Fair Value assessment.

Corporate developments reported alongside the Form 4 include an announcement that Wiseman intends to retire by June 30, 2026. The company has also seen active coverage from equity research firms in recent sessions.

Raymond James maintained an Outperform rating on Braze, pointing to international revenue growth of 26% year-over-year and U.S. revenue growth of 23% year-over-year when excluding contributions from Decisioning Studio. That firm raised its price target to $27.00, citing strong fourth-quarter bookings and what it described as broad-based acceleration across key performance indicators.

Piper Sandler kept an Overweight rating on the shares while trimming its price target to $27 from $30, referencing Braze’s guidance for 20% year-over-year revenue growth for fiscal 2027. UBS also adjusted its target downward to $28 from $43 but retained a Buy rating, noting 50% bookings growth and a third consecutive quarter of accelerating organic revenue growth.

Taken together, the reported insider sale, an impending leadership exit, and varied analyst target revisions reflect a mix of governance and performance-related news in the company’s public record. For investors seeking further detail on Braze’s financials and executive activity, a Pro Research Report covering this and other U.S. equities is available via InvestingPro.


Key points

  • Susan Wiseman sold 35,000 Class A shares on April 9, 2026, at a weighted average price of $20.29, totaling $710,150.
  • The share price has fallen 18% in the last week and 45% year-to-date; InvestingPro’s Fair Value assessment suggests the stock may be undervalued at current levels.
  • Analysts issued mixed adjustments: Raymond James raised its target to $27 with an Outperform, Piper Sandler reduced its target to $27 while keeping Overweight, and UBS trimmed its target to $28 but maintained a Buy rating.

Risks and uncertainties

  • Insider selling occurs alongside a planned executive retirement - governance changes can create short-term uncertainty for investors and markets sensitive to leadership transitions.
  • Significant recent equity price declines - market volatility for the stock could affect investor execution and portfolio valuations.
  • Analyst price target revisions are mixed - divergent broker assessments point to uncertainty about near-term valuation consensus and growth expectations.

Risks

  • Leadership transition risk from Susan Wiseman’s planned retirement by June 30, 2026 could create short-term governance uncertainty.
  • Market risk from the recent sharp share-price decline could affect investor sentiment and portfolio performance.
  • Valuation and expectation risk highlighted by mixed analyst price-target changes may reflect uncertainty about future revenue trajectories and bookings.

More from Insider Trading

NeonC Technologies C.A.O. David Suh Jr. Buys $1,000 of Stock as Company Advances Financing and Clinical Program Apr 13, 2026 Carlson Capital Reduces RWAY Stake With $3.69M Sale as Runway Reports Weaker Quarter Apr 13, 2026 Hippo CEO Disposes of $130,250 in Stock; Company Signals Ongoing Operational Momentum Apr 13, 2026 Liquidia CEO Executes $1.00M Share Sale as Company Advances Yutrepia Launch Apr 13, 2026 Liquidia CFO Executes $5.3M Stock Sale After Strong Yutrepia Quarter Apr 13, 2026